References
- Smart C R, Hartmann W H, Beahrs O H, Garfinkel L. Insights into breast cancer screening of younger women. Cancer 1993; 72((Suppl))149–56
- Lundgren B, Jakobsson S. Single view mammography. A simple and efficient approach to breast cancer screening. Cancer 1976; 38: 1124–9
- Shapiro S. Evidence on screening for breast cancer from a randomized trial. Cancer 1997; 30((Suppl))2772–82
- Tabar L, Fagerberg C JG, Gad A, et al. Reduction in mortality from breast cancer after mass screening with mammography. Lancet 1985; 1: 829–32
- Andersson J, Aspegren K, Janzon L, et al. Mammographic screening and mortality from breast cancer: the Malmö mammographic screening trial. BMJ 1988; 297: 943–8
- Frisell J, Lidbrink E, Hellström L, Rutqvist LE. Follow-up after 11 years. Update of mortality results in the Stockholm mammographic screening trial. Mammographic screening for breast cancer. Aspects on benefit and risks (Dissertation), E. Lidbrink. Karolinska Institute, Stockholm 1995
- Alexander F E, Anderson T J, Brown H K, et al. The Edinburgh randomised trial of breast cancer screening: results of 10 years of follow-up. Br J Cancer 1994; 70: 542–8
- Miller A B, Baines C J, To T, Wall C. Canadian National Breast Screening Study: Breast cancer detection and death rates among women aged 40 to 49 years. Can Med Assoc J 1992; 147: 1459–76
- Miller A B, Baines C J, To T, Wall C. Canadian National Breast Screening Study: 2. Breast cancer detection and death rates among women aged 50 to 59 years. Can Med Assoc J 1992; 147: 1477–88
- Nyström L, Rutqvist L E, Wall S, et al. Breast cancer screening with mammography: overview of Swedish randomised trials. Lancet 1993; 341: 973–8
- Nyström L, Larsson L G, Rutqvist L E, et al. Determination of cause of death among breast cancer cases in the Swedish randomised mammography screening trials. A comparison between official statistics and validation by an endpoint committee. Acta Oncol 1995; 34: 145–52
- Larsson L G, Nyström N, Wall S, et al. The Swedish randomised mammography screening trials: analysis of their effect on the breast cancer related excess mortality. J Med Screen 1996; 3: 129–32
- Wright C J, Mueller CB. Screening mammography and public health policy: the need for perspective. Lancet 1995; 346: 29–32
- Shapiro S. Determining the efficacy of breast cancer screening. Accomplishments in Cancer Research, J G Fortner, J E Rhoads. JB Lippincott, Philadelphia 1989; 61–74
- Larsson L G, Andersson I, Bjurstam N, et al. Updated overview of the Swedish randomized trials on breast cancer screening with mammography: age group 40–49 at randomization. JNCI 1997; 57–61, monograph No. 22
- Bjurstam N, Björmeld L, Duffy SW. The Gothenburg breast screening trial: preliminary results on breast cancer mortality for women aged 39–49. JNCI 1997; 53–5, monograph No. 22
- Peer van Dijck J, Hendriks J, Holland R, Verbeek A. Age-dependent growth rate of primary breast cancer. Cancer 1993; 71: 3547–51
- Tabar L, Fagerberg G, Chen H H, Duffy S W, Gad A. Tumour development, histology and grade of breast cancers: prognosis and progression. Int J Cancer 1996; 66: 413–9
- Thurfjell E L, Lindgren JA. Population-based mammography screening in Swedish clinical practice: prevalence and incidence screening in Uppsala county. Radiology 1994; 193: 351–7
- Lidbrink E, Elfving J, Frisell J, Johsson E. Neglected aspects of false positive findings of mammography in breast cancer screening: analyses of false positive cases from the Stockholm trial. BMJ 1996; 312: 273–312
- Fletcher S W, Black W, Harris R, Rimer B K, Shapiro S. Report of the international workshop on screening for breast cancer. JNCI 1993; 85: 1644–56
- NIH (1997) . Consensus development conference on breast cancer screening for women ages 40–49. Jan 21–23, 1997, Program and abstracts. National Inst. Health
- Leitch A M, Dodd G D, Constanza M, et al. American Cancer Society guidelines for the early detection of breast cancer: update 1997. CA Cancer J Clin 1997; 47: 150–3
- Sept., 1995, Eurotrial 40. A randomized population-based trial on the efficacy of screening mammography in women under 5. Study protocol. UICC, Geneva
- Breast cancer screening with mammography in women aged 40–49 years. Report of the organizing committee and collaborators, Falun, Sweden, March 1996. Int J Cancer 1996; 64: 693–99
- UICC Cancer Management Meeting, ViennaAustria, June 28-July 1, 1997. UICC, Geneva 1997, Breast cancer screening (Abstracts 001–005)
- Lerman C, Trock B, Rimer B K, Boyce A, Jepson C, Engstrom PF. Psychological and behavioral implications of abnormal mammograms. Ann Intern Med 1991; 114: 657–61
- Lidbrink E, Levi L, Petterson I, et al. Single-view screening mammography: psychological, endocrine and immunological effects of recalling for a complete three-view examination. Eur J Cancer 1995; 31A: 932–3